190 related articles for article (PubMed ID: 31743242)
21. Clinical epidemiology in chronic uremia.
Parfrey PS
Clin Invest Med; 1994 Oct; 17(5):466-73. PubMed ID: 7867252
[TBL] [Abstract][Full Text] [Related]
22. Impaired peripheral micro- and macrocirculation during hemodialysis in uremic patients.
Santesson P; Danielsson A; Iseda I; Adamson U; Lins PE; Jörneskog G
Int Angiol; 2010 Aug; 29(4):362-70. PubMed ID: 20671655
[TBL] [Abstract][Full Text] [Related]
23. Urea transporters and sweat response to uremia.
Keller RW; Bailey JL; Wang Y; Klein JD; Sands JM
Physiol Rep; 2016 Jun; 4(11):. PubMed ID: 27273880
[TBL] [Abstract][Full Text] [Related]
24. Pathophysiology of cardiovascular damage in the early renal population.
London G
Nephrol Dial Transplant; 2001; 16 Suppl 2():3-6. PubMed ID: 11369841
[TBL] [Abstract][Full Text] [Related]
25. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
26. How end-stage renal disease (ESRD)-Medicare developed.
Schreiner GE
Semin Nephrol; 1997 May; 17(3):152-9. PubMed ID: 9165644
[TBL] [Abstract][Full Text] [Related]
27. Changes in Na+, K+ concentrations in perspiration and perspiration volume with alternating current iontophoresis in palmoplantar hyperhidrosis patients.
Ohshima Y; Shimizu H; Yanagishita T; Watanabe D; Tamada Y; Sugenoya J; Tsuda T; Matsumoto Y
Arch Dermatol Res; 2008 Nov; 300(10):595-600. PubMed ID: 18677499
[TBL] [Abstract][Full Text] [Related]
28. [10-years' experience in using enterosorption for treating chronic kidney failure].
Lukichev BG; Shostka GD; Strelko VV; Azizova TS; Kavraĭskiĭ IuR; Panina IIu
Ter Arkh; 1992; 64(8):52-6. PubMed ID: 1440398
[No Abstract] [Full Text] [Related]
29. Emergency medicine evaluation and management of the end stage renal disease patient.
Long B; Koyfman A; Lee CM
Am J Emerg Med; 2017 Dec; 35(12):1946-1955. PubMed ID: 28893450
[TBL] [Abstract][Full Text] [Related]
30. Uremia Retention Molecules and Clinical Outcomes.
Barreto FC; Barreto DV; Canziani MEF
Contrib Nephrol; 2017; 191():18-31. PubMed ID: 28910788
[TBL] [Abstract][Full Text] [Related]
31. The influence of larger molecules on cellular response in uremia.
Giacchino F; Quarello F; Pozzato M; Giraudo G; Formica M; Quattrocchio G; Piccoli G
Trans Am Soc Artif Intern Organs; 1983; 29():29-32. PubMed ID: 6608816
[No Abstract] [Full Text] [Related]
32. Renal cell therapy in the treatment of patients with acute and chronic renal failure.
Humes HD; Weitzel WF; Fissell WH
Blood Purif; 2004; 22(1):60-72. PubMed ID: 14732813
[TBL] [Abstract][Full Text] [Related]
33. Uremic toxins, oxidative stress, and renal fibrosis: an interwined complex.
Chao CT; Chiang CK
J Ren Nutr; 2015 Mar; 25(2):155-9. PubMed ID: 25511523
[TBL] [Abstract][Full Text] [Related]
34. [Renal replacement therapy by hemodialysis: an overview].
Jacobs C
Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of uremia in frail elderly patients: the issue of prolonged conservative management].
De Biase V; Tobaldini O; Casarotti-Todeschini S; Gambaro G
G Ital Nefrol; 2007; 24(3):255-61. PubMed ID: 17554738
[TBL] [Abstract][Full Text] [Related]
36. Renal failure.
Tichy AM
Crit Care Update; 1980 Mar; 7(3):5-18. PubMed ID: 6900553
[No Abstract] [Full Text] [Related]
37. Pre-ESRD Dementia and Post-ESRD Mortality in a Large Cohort of Incident Dialysis Patients.
Molnar MZ; Sumida K; Gaipov A; Potukuchi PK; Fülöp T; Joglekar K; Lu JL; Streja E; Kalantar-Zadeh K; Kovesdy CP
Dement Geriatr Cogn Disord; 2017; 43(5-6):281-293. PubMed ID: 28448971
[TBL] [Abstract][Full Text] [Related]
38. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: access to ESRD treatments.
Hörl WH; de Alvaro F; Williams PF
Nephrol Dial Transplant; 1999; 14 Suppl 6():10-5. PubMed ID: 10528707
[TBL] [Abstract][Full Text] [Related]
39. How end-stage renal disease (ESRD)-medicare developed.
Schreiner GE
Am J Kidney Dis; 2000 Apr; 35(4 Suppl 1):S37-44. PubMed ID: 10766000
[TBL] [Abstract][Full Text] [Related]
40. Daily dialysis: is this a reasonable option for the new millennium?
Twardowski ZJ
Nephrol Dial Transplant; 2001 Jul; 16(7):1321-4. PubMed ID: 11427618
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
